Skip to main content

Health condition · Clinically reviewed

Pancreatic lesions and cysts, from incidental finding to a risk-stratified plan.

More pancreatic cysts and solid lesions are being spotted incidentally than ever before, thanks to routine cross-sectional imaging. Most are low risk - but knowing which type you have, and what it means, matters. See our dedicated guide on pancreatic cysts for a deeper look at cystic disease specifically.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against international consensus guidelines and NICE, with sources listed at the end.

  • 03

    Current for 2026

    Reflects modern risk-stratified management of incidental pancreatic findings on cross-sectional imaging.

Key facts

Pancreatic lesions at a glance.

The essentials, in plain English - what it covers, how it's found, and how it's assessed today. For cyst-specific detail, see our pancreatic cysts guide.

  • What it is

    A broad category covering cystic and solid pancreatic findings, most often spotted incidentally on a CT or MRI done for another reason.

  • Cystic lesions

    Pseudocysts, serous cystadenomas, mucinous cystic neoplasms and IPMN each carry a different level of risk and need different follow-up.

  • Solid lesions

    Solid findings need further characterisation to exclude a neuroendocrine tumour or early pancreatic cancer.

  • How common

    Incidental pancreatic cysts are found in a meaningful minority of abdominal scans, rising with age.

  • Key test

    MRI with MRCP is the main tool for characterising a cyst; endoscopic ultrasound with FNA adds fluid analysis when needed.

  • Management range

    From simple interval surveillance imaging through to surgical resection, depending on size, growth and high-risk features.

How the diagnosis is made

From an incidental finding to a clear plan.

The steps a specialist team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Incidental finding on imaging

    Most pancreatic lesions are first seen on a CT or MRI performed for an unrelated reason.

  2. 02

    Assessing

    Dedicated pancreatic protocol scan

    A follow-up MRI with MRCP, or pancreatic-protocol CT, characterises the lesion in detail.

  3. 03

    Assessing

    Cystic versus solid

    The scan sorts the lesion into a cystic type (pseudocyst, serous, mucinous, IPMN) or a solid lesion needing further work-up.

  4. 04

    Confirming

    Risk-feature review

    Size, growth rate, duct involvement, mural nodules and symptoms are checked against consensus criteria for "worrying" or "high-risk" features.

  5. 05

    Confirming

    Endoscopic ultrasound with FNA

    When imaging alone is inconclusive, EUS-guided fine-needle aspiration samples cyst fluid for cytology and tumour markers such as CEA.

  6. 06

    Preparing

    Multidisciplinary team discussion

    Pancreatic specialists, radiologists and, where relevant, surgeons agree a surveillance or intervention plan.

  7. 07

    Preparing

    Surveillance or resection

    Low-risk lesions typically enter an imaging surveillance programme; high-risk features prompt referral for surgical resection.

Typical timeline: an incidental finding to an agreed surveillance or treatment plan in a matter of weeks.

Symptoms

What pancreatic lesions actually look like.

Most cause nothing at all. A minority cause symptoms - and there are specific features that mean it's time to escalate.

  • No symptoms at all

    The great majority of pancreatic cysts and small solid lesions cause no symptoms and are found by chance.

  • Vague upper abdominal or back pain

    Larger lesions can cause a dull ache in the upper abdomen or back, sometimes worse after eating.

  • Jaundice

    A lesion pressing on the bile duct can cause yellowing of the skin or eyes and needs prompt assessment.

  • Unexplained weight loss

    Weight loss alongside a pancreatic lesion is a feature that warrants urgent further investigation.

  • New or worsening diabetes

    New-onset diabetes in someone with a pancreatic lesion can be a marker of an underlying solid tumour.

  • Recurrent pancreatitis

    Some cystic lesions, particularly IPMN, present with episodes of acute pancreatitis.

  • Growth on serial imaging

    A lesion enlarging between scans is one of the clearest signals for closer surveillance or intervention.

  • Red flag - mural nodule or duct dilation

    A mural nodule, thickened wall or main pancreatic duct dilation on imaging are high-risk features prompting specialist referral.

Treatment

How pancreatic lesions are managed.

Surveillance imaging for most, endoscopic ultrasound when clarity is needed, and surgery reserved for high-risk or symptomatic lesions.

  • Surveillance imaging

    Regular MRI or CT at set intervals for low-risk cysts without worrying features - the most common pathway.

  • MRI with MRCP

    The main non-invasive tool for characterising cyst type, size and any duct communication.

  • Endoscopic ultrasound with FNA

    Adds fine detail and fluid sampling for cytology and tumour markers when imaging alone is unclear.

  • Repeat EUS or shortened intervals

    Used when a lesion shows an intermediate risk profile that needs closer watching before a decision.

  • Symptom and diabetes monitoring

    Tracking new abdominal pain, jaundice or glucose changes alongside imaging surveillance.

  • Laparoscopic resection

    Minimally invasive removal for smaller, well-localised high-risk or symptomatic lesions.

  • Pancreatic surgery (Whipple or distal)

    Open resection reserved for high-risk IPMN, suspected malignancy or larger solid lesions.

  • Multidisciplinary team follow-up

    Ongoing specialist review to adjust the plan as a lesion changes over time.

What this guide is based on

The sources behind every claim on this page.

International consensus guidelines and UK national guidance, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your specialist knows your imaging and history and can tell you which parts apply to you. If in doubt, get seen.

  • International Association of Pancreatology / Fukuoka consensus guidelines on IPMN and mucinous cystic neoplasms.

  • European evidence-based guidelines on pancreatic cystic neoplasms.

  • American Gastroenterological Association guideline on the diagnosis and management of asymptomatic pancreatic cysts.

  • NICE. Referral guidance for suspected pancreatic and upper gastrointestinal cancer.

Red flags

When a pancreatic lesion needs urgent attention.

Most pancreatic lesions are managed with routine surveillance. These are the situations that aren't - and where a specialist opinion is needed promptly.

  • Painless jaundice

    Yellowing of the skin or eyes without pain, alongside a pancreatic lesion, needs urgent same-week assessment.

  • Unexplained weight loss

    Significant, unintentional weight loss with a known pancreatic lesion is a red flag for malignancy.

  • New-onset diabetes over 50

    Sudden diabetes in an older adult, especially with a pancreatic finding, warrants prompt specialist review.

  • Main duct IPMN

    Involvement of the main pancreatic duct carries a substantially higher risk of malignant change than side-branch disease.

  • Mural nodule or thickened cyst wall

    An enhancing mural nodule or thickened, irregular wall is a classic high-risk imaging feature.

  • Rapid cyst growth

    Growth of more than a few millimetres per year on surveillance imaging should prompt earlier specialist review.

  • Elevated CA 19-9

    A raised tumour marker alongside a solid or high-risk cystic lesion strengthens the case for urgent work-up.

  • Recurrent unexplained pancreatitis

    Repeated attacks without an obvious cause (gallstones, alcohol) should trigger a search for an underlying cystic lesion.

  • Family history of pancreatic cancer

    A strong family history changes the surveillance threshold and should always be flagged to the specialist team.

Living with it

A monitored condition, with a clear pathway.

Four things that make the biggest difference over time - keeping appointments, tracking symptoms, understanding your specific lesion, and weighing risk with your specialist.

A quiet reminder

Surveillance is a plan, not a delay.

Being monitored rather than operated on straight away is often the safest, evidence-based choice - not a sign that nothing is being done.

  1. 01 Attend

    Keep every surveillance appointment

    Surveillance only works if scans happen on schedule - missed appointments are the most avoidable risk.

  2. 02 Track

    Note new symptoms early

    New pain, jaundice, weight loss or worsening blood sugar between scans should be reported promptly, not saved for the next appointment.

  3. 03 Ask

    Understand your specific lesion type

    Pseudocyst, serous cystadenoma, mucinous lesion, IPMN and solid lesion all carry different risks - ask which one applies to you.

  4. 04 Discuss

    Weigh surgery risk against cancer risk

    Resection carries real surgical risk, so the decision to operate is always a balance - a good specialist will talk this through in detail.

Frequently asked

Everything we get asked about pancreatic lesions and cysts.

Quick answers on IPMN, cyst types, MRI/MRCP, EUS-FNA and when surgery is needed.

  • What is a pancreatic lesion or cyst?

    A general term for an abnormal area found on pancreatic imaging - it can be a fluid-filled cyst (such as a pseudocyst, serous cystadenoma, mucinous cystic neoplasm or IPMN) or a solid lesion needing further characterisation. Many are found incidentally on scans done for unrelated reasons.

  • Is a pancreatic cyst the same as pancreatic cancer?

    No. Most pancreatic cysts found incidentally are benign or carry very low cancer risk. A small number, particularly certain types of IPMN or mucinous cystic neoplasm, carry a higher risk of progressing to cancer over time, which is why risk-stratified surveillance matters.

  • What is IPMN?

    IPMN stands for intraductal papillary mucinous neoplasm - a cystic lesion arising from the pancreatic duct system. Side-branch IPMN generally carries lower risk than main-duct IPMN, and management follows international consensus criteria based on size and high-risk features.

  • How is a pancreatic cyst investigated?

    MRI with MRCP is usually the first dedicated test, giving detailed information on cyst type, size and duct involvement. When findings are unclear, endoscopic ultrasound with fine-needle aspiration (EUS-FNA) samples cyst fluid for cytology and tumour markers.

  • Will I need surgery for a pancreatic cyst?

    Most low-risk cysts are simply monitored with interval imaging rather than operated on. Surgery is reserved for cysts with high-risk features, such as a mural nodule, main duct involvement, concerning growth, or symptoms suggesting malignancy.

  • How often will I need scans?

    This depends on the type, size and risk features of your lesion, and is set out by your specialist team following consensus guidelines - it can range from annual imaging for very low-risk lesions to much more frequent review for higher-risk findings.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.